EMBARGOED FOR RELEASE: 11:10 A.M. (ET), MONDAY, MAY 11, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.1948?guestAccessKey=e893e729-c708-4b6a-82f5-751c1d55179c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051120
What The Study Did: Coronavirus disease 2019 (COVID-19) infection in North American pediatric intensive care units is described in this observational study, including how it presented, whether there were comorbidities, the severity of disease, therapeutic interventions, clinical trajectory and early outcomes.
Authors: Lara S. Shekerdemian, M.D., M.H.A., of Texas Children’s Hospital and Baylor College of Medicine in Houston, is the corresponding author.
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.